Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walid Shalata

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Medicina (Kaunas, Lithuania)|February 24, 2024
Perimyocarditis Associated with Immune Checkpoint Inhibitors: A Case Report and Review of the LiteratureWalid Shalata, Rachel Steckbeck, Amjad Abu Salman, et al.
JTO Clinical and Research Reports|September 30, 2021
Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid CancerWaleed Kian, Dina Levitas, Wafeek Alguayn, et al.
Journal of Clinical Medicine|October 28, 2023
Unexpected and Rare Sites of Metastasis in Oncologic PatientsWalid Shalata, Ashraf Abu Jama, Amjad Abu Salman, et al.
Frontiers in Oncology|March 3, 2023
Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanomaWalid Shalata, Rachel Steckbeck, Ilya Polishchuk, et al.
International Journal of Molecular Sciences|November 26, 2022
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic DrugsMuhammed Iraqi, Priyanka Bolel, Rhitajit Sarkar, et al.
Case Reports in Oncology|January 13, 2023
An Unusual Presentation of HCC in a Patient with No Underlying Liver Disease: A Case StudyAnton Osyntsov, Melanie Zemel, Nir Cohen, et al.
Cancers|August 29, 2024
The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor EffectsWalid Shalata, Omar Abu Saleh, Lena Tourkey, et al.
International Journal of Molecular Sciences|July 29, 2025
Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung CancerAlexander Yakobson, Ronen Brenner, Itamar Gothelf, et al.
Cancers|July 24, 2021
Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)Walid Shalata, Muhammed Iraqi, Baisali Bhattacharya, et al.
Journal of Clinical Medicine|March 25, 2022
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and TreatmentAbed Agbarya, Walid Shalata, Alfredo Addeo, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Medicina (Kaunas, Lithuania)|February 24, 2024
Perimyocarditis Associated with Immune Checkpoint Inhibitors: A Case Report and Review of the LiteratureWalid Shalata, Rachel Steckbeck, Amjad Abu Salman, et al.
JTO Clinical and Research Reports|September 30, 2021
Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid CancerWaleed Kian, Dina Levitas, Wafeek Alguayn, et al.
Journal of Clinical Medicine|October 28, 2023
Unexpected and Rare Sites of Metastasis in Oncologic PatientsWalid Shalata, Ashraf Abu Jama, Amjad Abu Salman, et al.
Frontiers in Oncology|March 3, 2023
Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanomaWalid Shalata, Rachel Steckbeck, Ilya Polishchuk, et al.
International Journal of Molecular Sciences|November 26, 2022
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic DrugsMuhammed Iraqi, Priyanka Bolel, Rhitajit Sarkar, et al.
Case Reports in Oncology|January 13, 2023
An Unusual Presentation of HCC in a Patient with No Underlying Liver Disease: A Case StudyAnton Osyntsov, Melanie Zemel, Nir Cohen, et al.
Cancers|August 29, 2024
The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor EffectsWalid Shalata, Omar Abu Saleh, Lena Tourkey, et al.
International Journal of Molecular Sciences|July 29, 2025
Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung CancerAlexander Yakobson, Ronen Brenner, Itamar Gothelf, et al.
Cancers|July 24, 2021
Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)Walid Shalata, Muhammed Iraqi, Baisali Bhattacharya, et al.
Journal of Clinical Medicine|March 25, 2022
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and TreatmentAbed Agbarya, Walid Shalata, Alfredo Addeo, et al.
Pageof 8